×
Close
Sign Up
Login
Home
Library S
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Pharmacology & Pharmacy
35334
Global Medical University
5186
Allergy
1797
Anatomy & Morphology
1557
Andrology
379
Anesthesia & Intensive Care
1283
Anesthesiology
5482
Audiology & Speech-Language Pathology
347
Behavioral Sciences
100
Biochemical Research Methods
7161
Biochemistry & Molecular Biology
30007
Biodiversity Conservation
325
Biology
8453
Biophysics
8235
Biotechnology & Applied Microbiology
8619
Cardiac & Cardiovascular Systems
31108
Cardiovascular & Respiratory Systems
1386
Cell & Tissue Engineering
698
Cell Biology
11207
Chemistry, Analytical
4295
Chemistry, Applied
10946
Chemistry, Medicinal
8741
Chemistry, Multidisciplinary
18538
Clinical Immunology & Infectious Disease
454
Clinical Medicine
8961
Clinical Neurology
16635
Clinical Psychology & Psychiatry
1312
Critical Care Medicine
3207
Dentistry, Oral Surgery & Medicine
13521
Dermatology
7470
Developmental Biology
6919
Ecology
645
Education, Scientific Disciplines
2078
Emergency Medicine
4092
Endocrinology, Metabolism & Nutrition
24509
Engineering, Biomedical
3776
Entomology
450
Environmental Medicine & Public Health
4726
Evolutionary Biology
268
Gastroenterology & Hepatology
12230
General & Internal Medicine
6967
Genetics & Heredity
15105
Geriatrics & Gerontology
5137
Gerontology
370
Health Care Sciences & Services
16195
Health Policy & Services
651
Hematology
5625
Immunology
24753
Infectious Diseases
13997
Integrative & Complementary Medicine
2935
Medical Ethics
1224
Medical Informatics
2273
Medical Laboratory Technology
419
Medicine, General & Internal
44315
Medicine, Legal
532
Medicine, Research & Experimental
17764
Microbiology
23308
Mycology
0
Nanoscience & Nanotechnology
5444
Neuroimaging
1411
Neurology
4551
Neurosciences
39762
Nursing
9717
Nutrition & Dietetics
7868
Obstetrics & Gynecology
8296
Oncology
52304
Ophthalmology
9732
Optics
4272
Orthopedics
11788
Orthopedics, Rehabilitation & Sports Medicine
1818
Otolaryngology
1592
Otorhinolaryngology
4868
Parasitology
1125
Pathology
5114
Pediatrics
21656
Peripheral Vascular Disease
4839
Pharmacology/Toxicology
12134
Physiology
8907
Polymer Science
533
Primary Health Care
871
Psychiatry
19109
Psychology
5220
Psychology, Applied
112
Psychology, Biological
389
Psychology, Clinical
812
Psychology, Developmental
244
Psychology, Educational
169
Psychology, Experimental
166
Psychology, Mathematical
0
Psychology, Multidisciplinary
1688
Psychology, Psychoanalysis
30
Psychology, Social
119
Public Health & Health Care Science
2248
Public, Environmental & Occupational Health
27119
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12411
Radiology, Nuclear Medicine & Medical Imaging
8122
Rehabilitation
3059
Remote Sensing
0
Reproductive Biology
2866
Reproductive Medicine
1201
Research/Laboratory Medicine & Medical Technology
3975
Respiratory System
7431
Rheumatology
6043
Social Sciences, Biomedical
1203
Substance Abuse
2759
Surgery
33813
Toxicology
4444
Transplantation
948
Tropical Medicine
300
Urology & Nephrology
13055
Veterinary Sciences
35
Virology
2505
Zoology
0
Channels
Medrxiv - Pharmacology and Therapeutics
258
AAPS JOURNAL
329
ACTA PHARMACOLOGICA SINICA
523
ADVANCED DRUG DELIVERY REVIEWS
0
ANTIVIRAL RESEARCH
0
CANCER CHEMOTHERAPY AND PHARMACOLOGY
379
CHEMICO-BIOLOGICAL INTERACTIONS
936
CHEMMEDCHEM
258
CLINICAL PHARMACOKINETICS
344
CLINICAL PHARMACOLOGY & THERAPEUTICS
239
CNS DRUGS
233
CNS NEUROSCIENCE & THERAPEUTICS
107
DRUG DISCOVERY TODAY
263
DRUG METABOLISM AND DISPOSITION
399
DRUG RESISTANCE UPDATES
208
DRUG SAFETY
323
DRUGS
479
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
710
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
639
EUROPEAN JOURNAL OF PHARMACOLOGY
1445
INTERNATIONAL IMMUNOPHARMACOLOGY
2732
INTERNATIONAL JOURNAL OF PHARMACEUTICS
1948
JOURNAL OF CONTROLLED RELEASE
1316
JOURNAL OF ETHNOPHARMACOLOGY
2272
JOURNAL OF FOOD AND DRUG ANALYSIS
169
JOURNAL OF PHARMACEUTICAL ANALYSIS
427
NATURE REVIEWS DRUG DISCOVERY
604
NEUROPHARMACOLOGY
0
NEUROPSYCHOPHARMACOLOGY
717
NEUROTOXICOLOGY
0
PHARMACOGENOMICS
11
PHARMACOLOGY & THERAPEUTICS
370
PHARMACOTHERAPY
54
THERAPEUTIC ADVANCES IN CHRONIC DISEASE
82
TOXICOLOGY AND APPLIED PHARMACOLOGY
0
TOXICOLOGY IN VITRO
477
VALUE IN HEALTH
20
VASCULAR PHARMACOLOGY
0
ANNALS OF PHARMACOTHERAPY
110
ANTIBIOTICS-BASEL
1968
BIOMEDICAL CHROMATOGRAPHY
222
BIOPHARMACEUTICS & DRUG DISPOSITION
16
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
0
CHEMOTHERAPY
77
CHINESE MEDICINE
406
CHIRALITY
70
CLINICAL NEUROPHARMACOLOGY
50
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
111
CLINICAL THERAPEUTICS
52
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
46
DOSE-RESPONSE
68
DRUG DEVELOPMENT RESEARCH
102
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
302
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
717
HUMAN & EXPERIMENTAL TOXICOLOGY
105
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE
0
INTERNATIONAL JOURNAL OF TOXICOLOGY
36
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH
172
JOURNAL OF ANTIBIOTICS
280
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
375
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
30
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
170
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
1850
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
505
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
176
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
0
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
0
JOURNAL OF PHARMACOLOGICAL SCIENCES
0
JOURNAL OF PHARMACY AND PHARMACOLOGY
18
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
556
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
121
PHARMACOGENOMICS & PERSONALIZED MEDICINE
325
PHARMACOLOGY
124
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
0
SKIN PHARMACOLOGY AND PHYSIOLOGY
69
THERAPEUTIC ADVANCES IN DRUG SAFETY
22
THERAPEUTIC DRUG MONITORING
158
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
50
INDIAN JOURNAL OF PHARMACOLOGY
16
JOURNAL OF APPLIED BIOMEDICINE
44
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
47
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
354
THERAPIE
374
SCIENTIA PHARMACEUTICA
97
ADMET AND DMPK
111
ADVANCED THERAPEUTICS
83
ADVANCES IN PHARMACOLOGY AND PHARMACY
135
ADVANCES IN TRADITIONAL MEDICINE
34
ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE
26
ASIAN JOURNAL OF PHARMACEUTICS
166
CANADIAN JOURNAL OF HOSPITAL PHARMACY
192
CURRENT DRUG THERAPY
20
EGYPTIAN PHARMACEUTICAL JOURNAL
42
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES
272
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
62
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION
212
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH
164
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY
29
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
129
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
288
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS
44
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES
39
JOURNAL OF PHARMACY PRACTICE
78
JOURNAL OF RESEARCH IN PHARMACY PRACTICE
40
RESEARCH JOURNAL OF PHARMACOGNOSY
98
PHARMACEUTICAL MEDICINE
64
PHARMACIA
140
PHARMACOECONOMICS-OPEN
276
PHARMACY
176
PHARMACY PRACTICE-GRANADA
31
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES
136
DRUGS & AGING
284
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
492
INVESTIGATIONAL NEW DRUGS
358
JOURNAL OF PHARMACEUTICAL INNOVATION
376
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
180
NEUROTHERAPEUTICS
355
PEDIATRIC DRUGS
204
THERAPEUTIC INNOVATION & REGULATORY SCIENCE
336
SCI Abstract
search
ALL
RECOMMENDED
+
Rucaparib induces mitochondrial fragmentation and apoptosis in prostate cancer cells by targeting Drp1
Mitochondrial dynamics, particularly the balance between fission and fusion, are critical in regulating cellular metabolis...
Investigational New Drugs
comment
0
thumb_up
0
A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes
As monotherapy, PARP inhibitors have little cytotoxic effect in tumors without homologous recombinant repair (HRR) alterat...
Investigational New Drugs
comment
0
thumb_up
0
Comparative analysis of the effects of PSPH and PHGDH inhibitors on tumor cell proliferation
Serine metabolism plays a pivotal role in supporting the rapid proliferation of tumor cells, with PHGDH recognized as a ke...
Investigational New Drugs
comment
0
thumb_up
0
Advanced strategies to overcome multidrug resistance in cancer therapy: progress in P-glycoprotein inhibitors, drug delivery, and personalized medicine
Multidrug resistance (MDR) appears to be a major challenge in cancer treatment, frequently leading to suboptimal clinical ...
Investigational New Drugs
comment
0
thumb_up
0
Association of different approvals with Chinese Society of Clinical Oncology recommendation levels for solid tumor drugs: a cross-sectional analysis
In China, many solid tumor drugs have been approved via the accelerated approval (AA) pathway. We extracted data regarding...
Investigational New Drugs
comment
0
thumb_up
0
Targeting the TRIB3–MYC axis in cancer: mechanistic insights and therapeutic disruption strategies
The oncogenic transcription factor MYC drives proliferation, metabolism, and therapy resistance in the majority of human c...
Investigational New Drugs
comment
0
thumb_up
0
Targeting the Keap1/Nrf2 axis in cancer: molecular mechanisms and pharmacological interventions
The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is the first-line regulator of a plethora of c...
Investigational New Drugs
comment
0
thumb_up
0
Safety and efficacy of semi-dose venetoclax plus azacitidine in unfit acute myeloid leukemia patients in China: a real-world single-center study
Acute myeloid leukemia (AML) carries a poor prognosis in elderly or medically unfit patients, with median overall survival...
Investigational New Drugs
comment
0
thumb_up
0
Evaluation of the anti-leukemia activity and underlying mechanisms of the novel perinucleolar compartment inhibitor CTI-2 in acute myeloid leukemia
Acute myeloid leukemia (AML) is a malignant clonal hematological tumor originating from immature myeloid cells and is the ...
Investigational New Drugs
comment
0
thumb_up
0
Direct functional HOXA9/DNA-binding competitors versus epigenetic inhibitors of HOXA9 expression on cell proliferation, death and differentiation processes in the model of MLL-rearranged acute myeloid leukemia
Recent progress in cancer treatment has led to the development of advanced therapies targeting specific oncogenic drivers,...
Investigational New Drugs
comment
0
thumb_up
0
Synergistic effects of the curcumin analog HO-3867 and olaparib in transforming fallopian tube epithelial cells
Ovarian cancer remains one of the most lethal gynecologic malignancies, largely due to high recurrence rates and treatment...
Investigational New Drugs
comment
0
thumb_up
0
Anti-CD47 tri-specific killer engager enhances NK cell cytotoxicity against lung cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide, with immune evasion posing a major therapeutic c...
Investigational New Drugs
comment
0
thumb_up
0
Clinical characteristics, treatment and prognosis of pembrolizumab induced myocarditis
To explore the regularity and clinical characteristics of pembrolizumab induced myocarditis, and to provide a reference fo...
Investigational New Drugs
comment
0
thumb_up
0
The multifaceted role of KIF15 in cancer progression and therapy
Kinesin family member 15 (KIF15), a kinesin superfamily motor protein, is known to be involved in mitotic spindle formatio...
Investigational New Drugs
comment
0
thumb_up
0
Phase 1/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor–relapsed tumors
We report a phase 1/2 study evaluating EDP1503 (capsule containing Bifidobacterium animalis lactis) ± pem...
Investigational New Drugs
comment
0
thumb_up
0
Tackling tumor hypoxia: advances in breaking the oncogenic HIF-1α–p300/CBP alliance
The ability of tumor cells to survive under low-oxygen conditions is largely attributed to the hypoxia-inducible factor-1 ...
Investigational New Drugs
comment
0
thumb_up
0
Clinical potential of antibody–drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors
Recently, comprehensive genomic profiling (CGP)-matched therapy and antibody–drug conjugates (ADCs) have garnered in...
Investigational New Drugs
comment
0
thumb_up
0
Assessing the risks and benefits of investigational new drugs in adult phase-I oncology trials in China, 2013–2021
Previous research shows that the benefits of phase-I oncology trials increased from 5 to 18% between 2000 and 2019 globall...
Investigational New Drugs
comment
0
thumb_up
0
Beyond the obvious: targeting the SLC transportome and non-canonical drug transport mechanisms in cancer therapy
The solute carrier (SLC) superfamily comprises a broad array of membrane-bound transport proteins that are integral to the...
Investigational New Drugs
comment
0
thumb_up
0
Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance
Adolescents and young adults (AYA) are disproportionately affected by human immunodeficiency virus (HIV) globally, with hi...
Pharmacoeconomics-open
comment
0
thumb_up
0
Exploratory Cost-Effectiveness of a Novel Bioprosthetic Valve for Surgical Aortic Valve Replacement in Spain
Limited information is available regarding the impact of valve choice for patients with aortic stenosis (AS) undergoing su...
Pharmacoeconomics-open
comment
0
thumb_up
0
Adjusting Health State Utility Values for Multiple Conditions: Real-World EQ-5D-3L Data Modeling in Brazil
Decision analytical models are typically included in health economic evaluations to represent clinical pathways and enable...
Pharmacoeconomics-open
comment
0
thumb_up
0
An Enhanced Retention Strategy to Prevent the Vertical Transmission of HIV in Uganda: A Budget Impact Analysis
Novel retention strategies have the potential to reduce vertical transmission of HIV and improve patient outcomes for wome...
Pharmacoeconomics-open
comment
0
thumb_up
0
Real-World Analysis of Healthcare Utilization, Treatment Patterns, and Economic Burden in Medicare Beneficiaries with Parkinson’s Disease: Implications by Levodopa Formulation and Disease Severity
This study aimed to evaluate healthcare utilization, costs, and treatment patterns of Medicare beneficiaries with Parkinso...
Pharmacoeconomics-open
comment
0
thumb_up
0
Cost-Effectiveness of the CADScor System in Low-Risk Patients Presenting to the Emergency Department with Chest Pain
Studies have shown that up to 13% of patients presenting to the emergency department (ED) with low-risk chest pain receive...
Pharmacoeconomics-open
comment
0
thumb_up
0
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations
Productivity is utilised inconsistently in value assessment and poses methodological and conceptual challenges for estimat...
Pharmacoeconomics-open
comment
0
thumb_up
0
Economic Evaluation of Lecanemab for Early Symptomatic Alzheimer's Disease in South Korea
Alzheimer's disease (AD) exerts a considerable economic burden on South Korea's aging population. Lecanemab, an am...
Pharmacoeconomics-open
comment
0
thumb_up
0
Cost-Effectiveness of an Insertable Cardiac Arrhythmia Monitor after Non-ST-Elevation Myocardial Infarction in the UK
Patients surviving a non-ST-elevation myocardial infarction (NSTEMI) have an elevated risk of future major adverse cardiov...
Pharmacoeconomics-open
comment
0
thumb_up
0
Economic Evaluation of Treatment With Trastuzumab Deruxtecan for HER2-Low Advanced or Metastatic Breast Cancer in Previously Treated Patients
This study evaluates the efficiency and budgetary impact of trastuzumab deruxtecan (T-DXd) compared with standard therapy ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health System
Higher-risk myelodysplastic syndromes (HR-MDS) may be difficult to diagnose because patients present with nonspecific sign...
Pharmacoeconomics-open
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin